Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma or Multiple Myeloma
Conditions: Relapse or Refractory Acute Myeloid Leukemia; Relapse or Refractory Non-Hodgkin Lymphoma; Relapse or Refractory Multiple Myeloma Intervention: Drug: S65487 Sponsors: Institut de Recherches Internationales Servier; ADIR, a Servier Group company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acute Leukemia | Acute Myeloid Leukemia | Leukemia | Lymphoma | Myeloma | Non-Hodgkin's Lymphoma | Study